Addressing the unmet need for a comprehensive lung cancer registry in Romania.
Romania
cancer registry
data-driven policy-making
epidemiological monitoring
lung cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
04
2023
accepted:
01
06
2023
medline:
30
6
2023
pubmed:
30
6
2023
entrez:
30
6
2023
Statut:
epublish
Résumé
In this perspective article, we describe the vital need for a well-organized cancer registry in Romania, where lung cancer prevalence and mortality rates are alarmingly high. We discuss contributing factors such as increased use of chest X-rays and CT scans during the COVID-19 pandemic and delayed diagnoses due to limited medical care access. With the nation's characteristically limited access to healthcare, it is plausible that the surge in acute imaging for COVID-19 has inadvertently resulted in a higher detection rate of lung cancer. This inadvertent early detection underscores the vital need for a well-organized cancer registry in Romania, where lung cancer prevalence and mortality rates are alarmingly high. Although impactful, these factors are not the primary causes of the high lung cancer cases in the country. We provide an overview of current options and propose future perspectives for epidemiological monitoring of lung cancer patients in Romania, aiming to enhance patient care, bolster research, and promote data-driven policy-making. While our primary focus is establishing a national registry for lung cancer, we address challenges, considerations, and best practices applicable to all cancer types. Through our proposed strategies and recommendations, we aim to contribute to the development and improvement of a comprehensive national cancer registry system in Romania.
Identifiants
pubmed: 37388228
doi: 10.3389/fonc.2023.1211533
pmc: PMC10303923
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1211533Informations de copyright
Copyright © 2023 Olteanu, Oancea, Catalin, Trifa and Dascalu.
Déclaration de conflit d'intérêts
Author SD is employed by Dig Worldwide Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
Patterns (N Y). 2023 Apr 14;4(4):100726
pubmed: 37123439
Environ Health Perspect. 2011 Jun;119(6):860-5
pubmed: 21227886
Cancers (Basel). 2022 Nov 21;14(22):
pubmed: 36428798
Cell Oncol. 2007;29(1):19-24
pubmed: 17429138
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Clin Epidemiol. 2016 Oct 25;8:537-541
pubmed: 27822096
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Int J Epidemiol. 1993 Jun;22(3):369-76
pubmed: 8359950
Int J Epidemiol. 2020 Feb 1;49(1):246-258
pubmed: 30993317
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur J Cancer. 2010 Jan;46(2):395-404
pubmed: 19811904